Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 12, Issue 6, Pages 1418-1429
Publisher
Informa UK Limited
Online
2016-02-03
DOI
10.1080/21645515.2015.1136039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapeutic Effects of Dendritic Cells Pulsed with a Coden-optimized HPV 16 E6 and E7 Fusion Gene in Vivo and in Vitro
- (2015) Zhi-Xiang Zhou et al. Asian Pacific Journal of Cancer Prevention
- Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
- (2015) L. M. Draper et al. CLINICAL CANCER RESEARCH
- Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C
- (2015) Diane M. Da Silva et al. CLINICAL IMMUNOLOGY
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- FDA approves new upgraded Gardasil 9
- (2015) Tony Kirby LANCET ONCOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
- (2015) Ninh M. La-Beck et al. PHARMACOTHERAPY
- Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
- (2015) Benjamin Yang et al. Cell and Bioscience
- T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
- (2015) R. Houot et al. Cancer Immunology Research
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
- (2015) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Inhibition of Langerhans Cell Maturation by Human Papillomavirus Type 16: A Novel Role for the Annexin A2 Heterotetramer in Immune Suppression
- (2014) A. W. Woodham et al. JOURNAL OF IMMUNOLOGY
- Identification of novel epitopes from human papillomavirus type 18 E7 that can sensitize PBMCs of multiple HLA class I against human cervical cancer
- (2014) Sunghoon Kim et al. Journal of Translational Medicine
- Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype
- (2014) Diane M. Da Silva et al. VIROLOGY
- Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
- (2014) Tae Jin Kim et al. Nature Communications
- High Level of Tregs Is a Positive Prognostic Marker in Patients with HPV-Positive Oral and Oropharyngeal Squamous Cell Carcinomas
- (2014) E. Lukesova et al. Biomed Research International
- ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
- (2014) Robert G Petit et al. Journal for ImmunoTherapy of Cancer
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing
- (2013) Shengli Song et al. Cellular & Molecular Immunology
- Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
- (2013) Wen Yang et al. IMMUNOLOGY
- Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study
- (2013) Mark E. Scott et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization and evaluation of the immune responses elicited by a novel human papillomavirus (HPV) therapeutic vaccine: HPV 16E7-HBcAg-Hsp65 fusion protein
- (2013) Chao-Ming Zhou et al. JOURNAL OF VIROLOGICAL METHODS
- Sexually Transmitted Infections Among US Women and Men
- (2013) Catherine Lindsey Satterwhite et al. SEXUALLY TRANSMITTED DISEASES
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
- (2012) Debbie Saslow et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth
- (2012) Aline Bolpetti et al. BMC IMMUNOLOGY
- Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
- (2012) S. Tan et al. CURRENT CANCER DRUG TARGETS
- Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region
- (2012) Hisham Mehanna et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia
- (2012) Bethânea Crema Peghini et al. HUMAN IMMUNOLOGY
- Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice
- (2012) S Domingos-Pereira et al. Mucosal Immunology
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Global Burden of Human Papillomavirus and Related Diseases
- (2012) David Forman et al. VACCINE
- Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value
- (2012) Niladri Ganguly CELLULAR ONCOLOGY
- Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation
- (2012) Naoko Kajitani et al. Frontiers in Microbiology
- High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
- (2011) Mark H. Stoler et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
- (2011) Thomas C. Wright et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
- (2011) Jean-Luc Brun et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Identification of novel immunogenic human leukocyte antigen-A*2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer
- (2011) Sunphil Jang et al. CANCER
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Burden of cervical cancer in the United States, 1998-2003
- (2010) Meg Watson et al. CANCER
- BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination
- (2010) Laurent Derré et al. JOURNAL OF CLINICAL INVESTIGATION
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium
- (2010) C. L. Trimble et al. JOURNAL OF IMMUNOLOGY
- Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3
- (2009) Cornelia L. Trimble et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
- (2009) Niladri Ganguly et al. JOURNAL OF BIOSCIENCES
- Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
- (2009) L. M. Fahey et al. JOURNAL OF IMMUNOLOGY
- A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape
- (2009) L. M. Fahey et al. JOURNAL OF IMMUNOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
- (2008) C. L. Trimble et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started